Additional preliminary testing has shown efficacy on other enveloped/non-enveloped viruses and bacteria, as well as expressing no acute toxicity. The formulation tested on the SARS-CoV-2 virus is classified as non-corrosive for 316L stainless steel samples and is ranked “Excellent” in accordance with the Corrosion Resistance tables. Tygrus believes that Tydracide may enable the development of a new class of acidic antimicrobial products for hard surface disinfection and other applications.
"Tydracide demonstrates remarkable antiviral and antibacterial activity, exemplified by its ability to completely inactivate SARS-CoV-2 in one minute using the industry standard viral suspension test," stated Joseph DeVito, PhD, Tygrus' microbiology consultant. "A second round of testing is underway using hard surface disinfecting protocols with results expected soon.”
Tydracide is not currently available for sale. Tygrus anticipates placing Tydracide on the market in the U.S. upon EPA registration.
"Tygrus is in discussions with international distribution partners and we are prepared to ship product to international customers that have obtained country-specific regulatory approval of our new chemistry," stated Dan Jenuwine, Tygrus’ Chief Executive Officer.
Tygrus operates a state-of-the-art manufacturing facility in Madison Heights, Michigan which has production capacity to manufacture enough active ingredient to produce more than two million gallons per week of formulated, finished product.
About Tygrus LLC
Tygrus is a technology, manufacturing, and licensing company that has developed new, patented chemistries. Tygrus’ vision is to Better Everything by replacing hazardous chemistries with safer, less toxic alternatives across a wide variety of applications in multiple vertical markets. www.tygrus.com
Forward-Looking Statements
This press release may contain projections or other forward-looking statements regarding future events or our future financial performance. All statements other than present and historical facts and conditions contained in this release, including any statements regarding our future results of operations and financial positions, business strategy, plans and our objectives for future operations, are forward-looking statements (within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended). These statements are only predictions and reflect our current beliefs and expectations with respect to future events and are based on assumptions and subject to risk and uncertainties and subject to change at any time. We operate in a very competitive and rapidly changing environment. New risks emerge from time to time. Given these risks and uncertainties, you should not place undue reliance on these forward-looking statements. Actual events or results may differ materially from those contained in the projections or forward-looking statements. Forward-looking statements in this release are made pursuant to the safe harbor provisions contained in the Private Securities Litigation Reform Act of 1995.
